Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Innovation in the pharmaceutical industry: New estimates of R&D costs.
DiMasi JA, Grabowski HG, Hansen RW. DiMasi JA, et al. J Health Econ. 2016 May;47:20-33. doi: 10.1016/j.jhealeco.2016.01.012. Epub 2016 Feb 12. J Health Econ. 2016. PMID: 26928437
New drug development in the United States from 1963 to 1990.
DiMasi JA, Bryant NR, Lasagna L. DiMasi JA, et al. Clin Pharmacol Ther. 1991 Nov;50(5 Pt 1):471-86. doi: 10.1038/clpt.1991.172. Clin Pharmacol Ther. 1991. PMID: 1934860 No abstract available.
New indications for already-approved drugs: an analysis of regulatory review times.
DiMasi JA, Kaitin KI, Fernandez-Carol C, Lasagna L. DiMasi JA, et al. J Clin Pharmacol. 1991 Mar;31(3):205-15. doi: 10.1002/j.1552-4604.1991.tb04963.x. J Clin Pharmacol. 1991. PMID: 2019661
Cost of innovation in the pharmaceutical industry.
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. J Health Econ. 1991 Jul;10(2):107-42. doi: 10.1016/0167-6296(91)90001-4. J Health Econ. 1991. PMID: 10113009
Rising research and development costs for new drugs in a cost containment environment.
DiMasi JA. DiMasi JA. Pharmacoeconomics. 1992;1(Suppl 1):13-20. doi: 10.2165/00019053-199200011-00006. Pharmacoeconomics. 1992. PMID: 10146926
Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. Pharmacoeconomics. 1995 Feb;7(2):152-69. doi: 10.2165/00019053-199507020-00007. Pharmacoeconomics. 1995. PMID: 10155302
New drug development in the United States from 1963 to 1999.
Dimasi JA. Dimasi JA. Clin Pharmacol Ther. 2001 May;69(5):286-96. doi: 10.1067/mcp.2001.115132. Clin Pharmacol Ther. 2001. PMID: 11371996 No abstract available.
Risks in new drug development: approval success rates for investigational drugs.
Dimasi JA. Dimasi JA. Clin Pharmacol Ther. 2001 May;69(5):297-307. doi: 10.1067/mcp.2001.115446. Clin Pharmacol Ther. 2001. PMID: 11371997 No abstract available.
Emerging role of pharmacoeconomics in the research and development decision-making process.
DiMasi JA, Caglarcan E, Wood-Armany M. DiMasi JA, et al. Pharmacoeconomics. 2001;19(7):753-66. doi: 10.2165/00019053-200119070-00004. Pharmacoeconomics. 2001. PMID: 11548911
A New Look At United States Drug Development and Approval Times.
DiMasi JA. DiMasi JA. Am J Ther. 1996 Sep;3(9):647-657. doi: 10.1097/00045391-199609000-00008. Am J Ther. 1996. PMID: 11862306
47 results
Jump to page
Feedback